Calcarea Sulphurica 6X Tablets — Class II drug recall D-0493-2020
Terminated recall by Washington Homeopathic Products, Inc., reported 2019-11-27, distributed nationwide. CGMP Deviations: products were not manufactured under current good manufacturing practices.
| Recall number | D-0493-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Washington Homeopathic Products, Inc., Berkeley Springs, WV, United States |
| Recall initiated | 2019-11-08 |
| Classified | 2019-11-18 |
| Reported by FDA | 2019-11-27 |
| Terminated | 2023-01-04 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, SA |
| Quantity | 300 bottles |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00740640641903 |
| Lot numbers | BR18B277 |
Product
Calcarea Sulphurica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64190 3.
Reason for recall
CGMP Deviations: products were not manufactured under current good manufacturing practices.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0493-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.